Every CFO has seen network adequacy framed as a cost center. The numbers say otherwise — when you quantify deficiency response, delayed market entry, enrollment freeze risk, and QBP exposure, the ROI on proactive network investment is not ambiguous.
The Cost-Center Frame Is Wrong
In most Medicare Advantage organizations, network adequacy sits in the compliance function. It has a compliance budget, a compliance headcount, and a compliance success metric: no deficiency notices. When leadership asks the CFO about network adequacy spend, the answer is typically a cost figure — staffing, contracting support, credentialing resources — with an implicit justification that it is the price of regulatory compliance.
That framing is financially incorrect, and it leads to underinvestment in a function that has direct, quantifiable revenue consequences. Network adequacy is not a cost center that prevents fines. It is a revenue enabler whose failures generate costs that are typically five to ten times the cost of preventing them — and a revenue protector whose lapses can destroy Quality Bonus Payment eligibility, delay market entry, and expose plans to enrollment limitations that dwarf any compliance budget line.
The CFO who reframes network adequacy as a revenue protection function — and builds the financial model to support that reframe — will make different investment decisions than the CFO who treats it as overhead. Those different decisions are worth millions annually in plans above even moderate enrollment scale.
Quantifying Deficiency Response Costs
A deficiency notice is not a letter. It is an operational event that generates direct costs across multiple functions simultaneously, and those costs accumulate rapidly.
The direct remediation cost begins with the staff hours required to analyze the deficiency, identify the gap counties and specialties, develop a remediation plan, and manage the response process. For a deficiency involving multiple counties across two or three specialties — which is typical rather than exceptional — a dedicated compliance and network team can spend 400 to 600 hours on deficiency response, excluding any contracting or credentialing activity. At fully loaded labor cost, that is a $60,000 to $100,000 event before the first provider is contacted.
The contracting cost of emergency remediation is structurally higher than planned-cycle contracting. When a plan needs a provider in a specific county within 30 days to close a deficiency, the contracting team negotiates from a position of visible need. Providers in that situation receive better rates, shorter contract terms, and more favorable administrative arrangements than the same providers would have agreed to in a normal build cycle. Plans that have quantified their emergency contracting rate differential typically find it runs 8–15% above normal-cycle rates for the same provider types.
The credentialing acceleration cost adds another layer. Normal credentialing takes 60 to 90 days. Emergency credentialing — expedited processing, priority committee review, supplemental primary source verification — costs additional resources and, in some cases, requires outside credentialing support. That cost is avoidable under any normal-cycle build timeline and is entirely attributable to the deficiency event.
The Cost of Delayed Market Entry
Network adequacy failures in a new market — a county expansion, a new service area, or a new product type — are not just compliance problems. They are revenue delays with a direct, calculable cost.
The math is simple: if a plan projects $X of premium revenue from enrollment in a new county or service area, and a network adequacy failure delays market entry by one quarter, the plan has lost one quarter of that projected revenue. At the margin, a single delayed county with 500 projected members generating $1,200 PMPM in premium revenue represents $600,000 in delayed revenue for a 90-day delay. At scale, market entry delays from network adequacy failures represent millions in foregone revenue per affected market.
The cost of building a compliant network in that county before the submission deadline is almost always a fraction of the foregone revenue from a delayed entry. The ROI calculation on proactive network investment is not subtle once this comparison is made explicit. Plans that treat network build as a budget item to minimize are optimizing for the wrong variable.
Enrollment Freeze Risk and QBP Exposure
Beyond deficiency remediation and market entry delay, inadequate networks create two downstream financial risks that rarely appear in compliance budgets but belong squarely in the CFO's financial model.
The first is enrollment freeze risk. CMS has the authority to impose enrollment limitations on plans with persistent or severe network adequacy failures. An enrollment freeze — even a partial one restricted to specific counties — halts member growth in the affected area. For a plan in growth mode, an enrollment freeze is not an abstract regulatory sanction. It is a direct cap on revenue in the affected market for the duration of the sanction. The revenue cost of an enrollment freeze on a growing plan is measured in millions of lost PMPM revenue for every month the freeze remains in effect.
The second is Quality Bonus Payment exposure, which deserves explicit attention in any financial model of network adequacy risk. CMS's QBP structure pays significant per-member-per-month bonuses to plans at 4.0 Stars and above, with enhanced bonuses at 4.5 Stars. Network adequacy gaps suppress CAHPS access scores, which reduce Star Ratings, which reduce or eliminate QBP eligibility.
For a plan with 75,000 members currently at 4.0 Stars, the difference between maintaining 4.0 Stars and falling to 3.5 Stars is approximately $400–$600 per member annually in lost bonus revenue — a $30 million to $45 million annual revenue impact. The network adequacy investment that prevents the access failures driving that Star Rating decline may cost $3 million to $5 million. The ROI on that investment is not ambiguous.
The question is never whether network adequacy investment costs money. The question is whether that cost is larger or smaller than the revenue consequences of inadequate networks. The answer is consistently smaller — often by a factor of five to ten.
Building the Internal Financial Case
The CFO who wants to make the internal case for proactive network investment has a straightforward financial model to build: four risk scenarios, each with a probability estimate and a dollar consequence.
Scenario one: deficiency notice in one specialty across three counties. Probability based on prior-year near-misses. Cost: remediation labor, emergency contracting differential, credentialing acceleration, and one quarter of projected revenue from the affected counties.
Scenario two: market entry delay in a planned expansion county due to network inadequacy at submission. Cost: one to two quarters of foregone premium revenue in that market.
Scenario three: Star Rating decline of 0.5 due to CAHPS access score suppression attributable to network gaps. Cost: QBP revenue impact at current enrollment, projected forward two years to capture the multi-year lag between adequacy failure and QBP revenue loss.
Scenario four: enrollment limitation in a high-growth market due to persistent adequacy deficiencies. Cost: projected member growth in the affected market over the limitation period, multiplied by average PMPM.
Sum the probability-weighted costs of those four scenarios. Compare that figure to the incremental cost of the network investment required to prevent them. In every health plan that has run this analysis with honest inputs, the investment is smaller than the risk. The network adequacy function is not a cost center. It is the cheapest revenue protection a Medicare Advantage plan can buy.